216 related articles for article (PubMed ID: 22655528)
1. Molecular profiling assays in breast cancer: are we ready for prime time?
Gökmen-Polar Y; Badve S
Oncology (Williston Park); 2012 Apr; 26(4):350-7, 361. PubMed ID: 22655528
[TBL] [Abstract][Full Text] [Related]
2. Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
Peintinger F
Curr Opin Obstet Gynecol; 2014 Feb; 26(1):21-6. PubMed ID: 24346126
[TBL] [Abstract][Full Text] [Related]
3. Is gene array testing to be considered routine now?
Paik S
Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
[TBL] [Abstract][Full Text] [Related]
4. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.
Albain KS; Paik S; van't Veer L
Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534
[TBL] [Abstract][Full Text] [Related]
5. Genomic subtypes in choosing adjuvant therapy for breast cancer.
Zelnak AB; O'Regan RM
Oncology (Williston Park); 2013 Mar; 27(3):204-10. PubMed ID: 23687790
[TBL] [Abstract][Full Text] [Related]
6. Molecular assays in breast cancer pathology.
O'Toole SA; Selinger CI; Millar EK; Lum T; Beith JM
Pathology; 2011 Feb; 43(2):116-27. PubMed ID: 21233672
[TBL] [Abstract][Full Text] [Related]
7. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in breast cancer.
Morris SR; Carey LA
Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
[TBL] [Abstract][Full Text] [Related]
9. Multigene assays and isolated tumor cells for early breast cancer treatment: time for bionetworks.
Roukos DH; Ziogas DE; Katsios C
Expert Rev Anticancer Ther; 2010 Aug; 10(8):1187-95. PubMed ID: 20735306
[TBL] [Abstract][Full Text] [Related]
10. Commercialized multigene predictors of clinical outcome for breast cancer.
Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
[TBL] [Abstract][Full Text] [Related]
11. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
12. Clinical roundtable monograph: a multidisciplinary approach to the use of oncotype DX in clinical practice.
Gradishar WJ; Hansen NM; Susnik B
Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-7. PubMed ID: 19536946
[TBL] [Abstract][Full Text] [Related]
13. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
Kaufmann M; Pusztai L;
Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
[TBL] [Abstract][Full Text] [Related]
14. Review of gene-expression profiling and its clinical use in breast cancer.
Stadler ZK; Come SE
Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
[TBL] [Abstract][Full Text] [Related]
15. An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile?
Nicolini A; Ferrari P; Fallahi P; Antonelli A
Future Oncol; 2012 Feb; 8(2):131-4. PubMed ID: 22335577
[TBL] [Abstract][Full Text] [Related]
16. Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer.
Henry NL; Hayes DF
Oncology (Williston Park); 2007 Oct; 21(11):1301-9; discussion 1311, 1314, 1319. PubMed ID: 18080616
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model.
Yang M; Rajan S; Issa AM
Cancer; 2012 Oct; 118(20):5163-70. PubMed ID: 22359236
[TBL] [Abstract][Full Text] [Related]
18. [Gene expression based multigene prognostic and predictive tests in breast cancer].
Pénzváltó Z; Mihály Z; Gyorffy B
Magy Onkol; 2009 Dec; 53(4):351-9. PubMed ID: 20071307
[TBL] [Abstract][Full Text] [Related]
19. [A Review Multigene Assays for Clinical Utility in Breast Cancer].
Araki K; Ito Y
Gan To Kagaku Ryoho; 2016 Nov; 43(11):1332-1340. PubMed ID: 27899774
[TBL] [Abstract][Full Text] [Related]
20. Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow.
Harbeck N; Sotlar K; Wuerstlein R; Doisneau-Sixou S
Cancer Treat Rev; 2014 Apr; 40(3):434-44. PubMed ID: 24138841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
